FDA

Israeli aesthetic medical company Sofwave Medical Ltd. (TASE: SOFW) has received FDA approval for its device based on ultrasound energy use to improve the appearance of hair. In order to receive approval Sofwave conducted…

Lisa Maree Williams/Getty Images News The $5 a share contingent value right in Astrazeneca's (NASDAQ:AZN) planned $1.1 billion purchase of Icosavax (NASDAQ:ICVX) is based on FDA approval of RSV vaccine candidate IVX-A12 and some sales…

Grandbrothers The FDA has alerted healthcare providers not to use Cardinal Health (NYSE:CAH) Monoject syringes with syringe pumps and patient-controlled analgesia, or PCA, pumps until it further evaluates reports of incompatibility.…

This section is Partnership Content suppliedThe content in this section is supplied by Business Wire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by Business Wire…

The U.S. Food and Drug Administration is considering a ban on certain hair-straightening chemicals that have been used by Black women for years and that research shows may increase the risk of uterine cancer. But Black hair stylists say…

IvelinRadkov The FDA has granted expanded approval for Merck’s (NYSE:MRK) oncology drug Keytruda in the treatment of non-small cell lung cancer, or NSCLC. Keytruda, also known as pembrolizumab, was approved as a neoadjuvant and…

Mohammed Haneefa Nizamudeen As the FDA continues to mull the fate of Amgen's lung cancer drug Lumakras, Sanofi is reportedly moving in on Mirati (NASDAQ:MRTX), which has developed a rival product called Krazati. Analysts appear to be…

© Reuters. FILE PHOTO: A vial labelled "Novavax COVID-19 Vaccine" is seen in this illustration taken January 16, 2022. REUTERS/Dado Ruvic/Illustration/File Photo By Sriparna Roy and Michael Erman (Reuters) -The U.S. Food and Drug…

© Reuters. FILE PHOTO: CVS Health logo is seen displayed in this illustration taken, May 3, 2022. REUTERS/Dado Ruvic/Illustration/File Photo (Reuters) -The U.S. Food and Drug Administration on Tuesday warned eight companies,…

Israeli commercial stage biopharmaceutical company BioLineRx Ltd. (Nasdaq: BLRX; TASE: BLRX) today announced that the US Food and Drug Administration (FDA) has approved APHEXDA (motixafortide) in combination with…